Female Pattern Hair Loss: Signs, Diagnosis and Treatment

Female pattern hair loss gradually reduces hair density, often widening the central part while preserving the frontal hairline.

Its medical name is female androgenetic alopecia. Susceptible hair follicles produce progressively finer, shorter hairs, so the scalp becomes more visible even when individual hairs continue to grow. The condition does not cause scarring of the follicle.

Female pattern hair loss commonly presents with reduced volume over the crown and a broader central part. A ponytail may feel thinner, and styling can become harder as hairs vary in thickness. The scalp usually looks normal rather than red, scaly or scarred.

Sudden handfuls of shedding, sharply defined bald patches, broken hairs, scalp pain or loss of eyebrows point toward another or additional cause and warrant assessment.

Inherited follicle sensitivity and hormonal signalling contribute to gradual miniaturisation. Genetics can come from either side of the family, and a clear family history is not always present. The growth phase shortens over time, producing hairs that provide less scalp coverage.

Pattern loss can coexist with temporary shedding after illness, major stress, nutritional deficiency or hormonal change. Treating a second cause may improve that added shedding without removing the underlying pattern tendency.

The change is generally gradual and may be easier to recognise in photographs than from day-to-day observation. Density can remain stable for periods and then decline further. Treatment aims to slow miniaturisation and preserve functioning follicles; any improvement requires continued monitoring and maintenance.

A family tendency increases susceptibility, and the pattern may become more noticeable with hormonal transitions and age. Signs such as irregular periods, new coarse facial hair or persistent acne can prompt evaluation for androgen excess. Tight hairstyles and chemical damage do not cause follicle miniaturisation, but they can add breakage or traction loss.

A dermatologist examines the distribution, hair-shaft thickness and scalp surface, often using magnification. Questions cover the pace of change, shedding, medicines, diet, recent illness, menstrual history and family patterns. A gentle pull test can help assess active shedding.

Blood tests may be selected when symptoms suggest anaemia, thyroid disease, nutritional deficiency or hormonal imbalance. A scalp biopsy is reserved for cases where the pattern is unclear or scarring alopecia must be excluded.

Topical minoxidil is a common starting treatment. Early temporary shedding or scalp irritation can occur, and benefit is maintained only while treatment continues. Keep it away from the face and wash hands after application to limit unwanted hair growth elsewhere.

A dermatologist may consider oral minoxidil or spironolactone for selected patients after reviewing blood pressure, medicines, pregnancy plans and relevant health conditions. These prescriptions require individualized safety advice. Platelet-rich plasma, mesotherapy and hair transplantation may be discussed, but suitability and expected benefit vary with follicle health and diagnosis.

Gentle detangling, lower-heat styling and looser hairstyles reduce avoidable breakage. Volumising cuts, scalp concealers, fibres, toppers or wigs can improve coverage without affecting medical treatment. Monthly photos in the same lighting and part position are more useful than daily hair counting for tracking gradual change.

Female pattern hair loss does not damage general physical health, but visible thinning can affect self-esteem, social comfort and mood. Anxiety about shedding may lead to frequent product changes that irritate the scalp. Emotional support is a valid part of care when hair loss is causing persistent distress.

Inherited susceptibility cannot be removed, yet early diagnosis may preserve more density by allowing treatment before miniaturisation advances. Avoid crash dieting, address identified deficiencies and reduce traction from tight styles. Supplements are not a substitute for testing because excess intake can also worsen hair concerns or interact with medicines.

Seek assessment when thinning is progressing, the cause is uncertain or the scalp has pain, scale or inflammation. Bring a medication and supplement list, details of recent illnesses or dietary changes, and older photographs showing the hairline and part. Mention pregnancy or plans to conceive because this changes which medicines are appropriate.